Syros Pharmaceuticals Management
Management Kriterienprüfungen 2/4
Syros Pharmaceuticals' CEO is Conley Chee, appointed in Dec 2023, has a tenure of less than a year. total yearly compensation is $1.04M, comprised of 46% salary and 54% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth $277.47K. The average tenure of the management team and the board of directors is 2.6 years and 11.6 years respectively.
Wichtige Informationen
Conley Chee
Geschäftsführender
US$1.0m
Gesamtvergütung
Prozentsatz des Geschäftsführergehalts | 46.0% |
Amtszeit als Geschäftsführer | less than a year |
Eigentum des Geschäftsführers | 0.5% |
Durchschnittliche Amtszeit des Managements | 2.6yrs |
Durchschnittliche Amtszeit der Vorstandsmitglieder | 11.6yrs |
Jüngste Management Updates
Recent updates
Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout
Jul 02Syros Pharmaceuticals: Rising Despite Dilution, A Must Look
Jan 14Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders
Sep 20Syros gets FDA orphan drug designation for pancreatic cancer treatment SY-5609
Sep 13Syros Pharmaceuticals Q2 2022 Earnings Preview
Aug 08Syros Pharmaceuticals Is A Buy As New Trials Start
Nov 20Syros Pharmaceuticals (NASDAQ:SYRS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 08Analyse der Geschäftsführervergütung
Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$98m |
Jun 30 2024 | n/a | n/a | -US$132m |
Mar 31 2024 | n/a | n/a | -US$144m |
Dec 31 2023 | US$1m | US$479k | -US$165m |
Vergütung im Vergleich zum Markt: Conley's total compensation ($USD1.04M) is above average for companies of similar size in the US market ($USD655.65K).
Entschädigung vs. Einkommen: Insufficient data to compare Conley's compensation with company performance.
Geschäftsführer
Conley Chee (54 yo)
less than a year
Amtszeit
US$1,041,697
Vergütung
Mr. Conley Chee serves as President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. since December 02, 2023. He served as Chief Commercial Officer at Syros Pharmaceuticals, Inc. since Se...
Führungsteam
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
CEO, President & Director | less than a year | US$1.04m | 0.46% $ 277.5k | |
Scientific Founder | no data | US$82.15k | 0.040% $ 24.2k | |
Chief Financial Officer | 3.1yrs | US$833.02k | 0.46% $ 282.1k | |
Chief Medical Officer | 8.9yrs | US$876.53k | 0% $ 0 | |
Founder | no data | keine Daten | keine Daten | |
Scientific Founder & Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Director of Corporate Communications & Investor Relations | no data | keine Daten | keine Daten | |
Chief Legal & Compliance Officer and Chief Business Officer | 2.1yrs | US$1.46m | 0.17% $ 105.7k | |
Vice President of Human Resources | 1.8yrs | keine Daten | keine Daten | |
Chief Development Officer | 4.4yrs | keine Daten | 0.094% $ 57.2k |
2.6yrs
Durchschnittliche Betriebszugehörigkeit
56yo
Durchschnittliches Alter
Erfahrenes Management: SYRS's management team is considered experienced (2.6 years average tenure).
Vorstandsmitglieder
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
CEO, President & Director | less than a year | US$1.04m | 0.46% $ 277.5k | |
Scientific Founder | 13yrs | US$82.15k | 0.040% $ 24.2k | |
Scientific Founder & Member of Scientific Advisory Board | 11.6yrs | keine Daten | keine Daten | |
Independent Chairman | 7.8yrs | US$110.40k | 0.060% $ 36.2k | |
Member of Scientific Advisory Board | 11.6yrs | keine Daten | keine Daten | |
Independent Director | 2.2yrs | US$78.53k | 0.060% $ 36.2k | |
Director | 11.6yrs | US$1.49m | 0.51% $ 307.3k | |
Member of Scientific Advisory Board | 11.6yrs | keine Daten | keine Daten | |
Member of Scientific Advisory Board | 11.6yrs | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | 11.6yrs | keine Daten | keine Daten | |
Member of Scientific Advisory Board | 11.6yrs | keine Daten | keine Daten |
11.6yrs
Durchschnittliche Betriebszugehörigkeit
63.5yo
Durchschnittliches Alter
Erfahrener Vorstand: SYRS's board of directors are seasoned and experienced ( 11.6 years average tenure).